The 27th Global Harmonization Task Force Annual Meeting on Medical Device Regulations was held in Shanghai.

From November 27 to 30, the 27th Annual Meeting of the Global Harmonization Working Party (GHWP) on Medical Device Regulations and the Technical Committee Meeting were held in Shanghai. Li Li, Secretary of the Party Leadership Group and Director of the National Medical Products Administration (NMPA), attended and addressed the conference.

Li Li stated that, as a major player in the medical device industry, China is continuously enhancing its innovation in medical device research and development, advancing the construction of regulatory standards, and engaging in extensive international regulatory exchanges and cooperation, thereby vigorously promoting the high-quality development of the industry. The GHWP is an important international organization in the global medical device field. The NMPA will participate more deeply in GHWP's various activities, strengthen regulatory exchanges and mutual learning with countries and regions around the world, jointly promote the convergence, harmonization, and trust in global medical device regulations, support global medical device technology innovation and cooperation, and make new and greater contributions to building a global health community.

During the annual meeting, NMPA Deputy Director Xu Jinghe and Murallitharan Paramasivam, Director of the Malaysian Medical Device Authority, jointly signed the "Memorandum of Understanding on Medical Device Cooperation between the National Medical Products Administration of the People's Republic of China and the Malaysian Medical Device Authority," reaching a consensus on further strengthening medical device regulatory exchanges and cooperation between the two countries.

This annual meeting was the first held in China since NMPA Deputy Director Xu Jinghe took office as GHWP Chair. Over 600 representatives from 25 countries and regions around the world attended the meeting. The four-day event focused on accelerating the convergence, harmonization, and trust in global medical device regulations through in-depth discussions and exchanges.